Diabetes and cardiometabolic companies sell simultaneously to patients, employers, payers, and clinicians, and each audience interprets value differently. Product marketing translates your clinical outcomes into a message each group can act on, equips sales with materials that stand up to a skeptical buyer, and helps your launches land. We create the messaging, positioning, and go-to-market motion so the market finally understands what your product does.
The Challenge
You use one message for four buyers who each care about something different
A patient wants to feel better and less alone, an employer wants lower claims, a payer wants budget predictability, and a clinician wants evidence and workflow fit. A single deck cannot serve all four, so a one-size message lands with none of them. Cardiometabolic companies that grow across these audiences without segmenting their messaging watch conversion stall at every stage. The fix is a messaging architecture with a distinct value story per audience, all rooted in the same product truth.
Your clinical evidence is buried in language that only your medical team understands
The strongest thing you have is often a clinical outcome, and it is written for a journal, not a buyer. When an employer benefits leader or a patient reads it, the value evaporates because the translation was never done. In cardiometabolic care the proof is the differentiator, so failing to make it legible is failing to sell. Product marketing turns the clinical result into a claim each audience can believe and repeat.
Sales is improvising because they lack materials that hold up to hard questions
When product marketing is missing, sales cobbles together their own decks, makes claims that were never cleared, and answers objections inconsistently. In a regulated clinical category that improvisation is both a conversion problem and a compliance risk. Every rep tells a slightly different story, and none of them is the strongest one. A real product marketing function gives sales a cleared, tested narrative and the objection handling to back it.
Your launches land with a thud because the market and funnel were never prepared
A new feature or clinical result ships, and the impact fizzles because there was no launch motion – no audience-specific messaging, no sales enablement, no coordinated push. Cardiometabolic buying cycles are long and multi-stakeholder, so an unsupported launch simply disappears. The engineering investment gets no commercial return. Product marketing is the function that turns a release into a go-to-market event that actually moves pipeline.
How We Can Help
We begin by uncovering the product truth. Before developing any messaging, we go deep on what the product actually does, the clinical evidence supporting it, and where it genuinely outperforms the alternative. In cardiometabolic health, that truth is typically a clinical outcome, and everything downstream must be honestly traceable to it, because a claim that cannot withstand scrutiny is a liability rather than an asset.
From that truth, we create a messaging architecture, not merely a slogan. We establish core positioning and then develop a distinct value story for every audience – patient, employer, payer, clinician – so each hears the benefit in their own terms while the underlying claim remains consistent and cleared. Most teams skip this part, which is why their message resonates a little with everyone but not enough with anyone.
Next, we translate proof into materials. We turn clinical evidence into claims each audience can trust, then create the assets that carry those claims: the sales narrative, objection handling, one-pagers, and decks. We clear the language against your regulatory posture from the start so sales no longer improvises claims that have never been reviewed.
For execution, we treat launches as go-to-market events. For a new feature or clinical result, we develop audience-specific messaging, brief and enable sales, and coordinate the push throughout the funnel so the release moves pipeline rather than fizzling out. We operate within your current marketing and sales rhythm instead of adding a separate process.
For measurement, we connect product marketing to the funnel: message resonance in demos, stage conversion, sales cycle length, and win rate against alternatives. If a message is not landing, the conversion data shows us, and we rewrite it. Product marketing that fails to move the funnel is decoration.
What sets us apart is that we work as embedded operators between product, sales, and the market – not as a team that delivers a messaging document and vanishes. Messaging in a multi-stakeholder clinical category only holds up when someone keeps it aligned with the product and tests it with real buyers, and that is where we remain.
What we deliver
- Product truth and evidence audit – what the product does, the clinical proof, and where it honestly wins
- Messaging architecture with a core positioning and a distinct, cleared value story per audience – patient, employer, payer, clinician
- Sales enablement kit – cleared narrative, objection handling, one-pagers, and decks that survive a skeptical buyer
- Launch motion for features and clinical results – audience-specific messaging, sales briefing, and coordinated funnel push
- Funnel-tied measurement – message resonance, stage conversion, cycle length, and win rate against alternatives
In cardiometabolic health, your greatest asset – the clinical outcome – is often your least understandable one. Product marketing serves as the translation layer, turning a journal result into a claim that a patient, employer, payer, and clinician can each trust and repeat.
Our Methodology
We deliver product marketing through a 90-day sprint. The first 30 days focus on the truth and evidence audit: we go deep on the product and its clinical proof, interview buyers across all four audiences, and identify where the product honestly wins. Days 30 to 60 cover the messaging build: we establish the core positioning, develop audience-specific value stories, clear the language with your regulatory stakeholders, and create the sales enablement kit. Days 60 to 90 focus on activation: we execute a real launch or re-message a live funnel, brief sales, and instrument the funnel to measure message resonance and conversion.
What distinguishes this from a traditional agency or a hire-and-hope PMM is that we do not hand over a messaging document and walk away. We remain embedded between product, sales, and the market, keep messaging aligned as the product evolves, and make it accountable to funnel metrics rather than the appearance of the deck. In a category with four audiences and a compliance line, messaging is an operating system, and we operate it.
Our Approach
The first 30 days focus on discovery and evidence. We go deep on the product and clinical proof, interview actual buyers across your four audiences, and identify where you honestly win and where the current message breaks down. You receive a clear-eyed assessment of which claims resonate and which ones your buyers do not trust.
Days 30 to 60 focus on the build. We establish positioning, develop value stories for each audience, clear claims with your regulatory contact, and create the sales enablement kit. We collaborate closely with sales because they must carry the narrative, and it needs to feel practical during a live call, not simply correct on paper.
Days 60 to 90 cover activation and measurement. We execute a launch or re-message an existing funnel, brief and enable sales, and instrument the funnel to assess message resonance and conversion. Most engagements last three to six months, and many become an ongoing product marketing function because each new feature and clinical result requires the same approach.
The cadence includes a weekly working session with your product and sales leads, along with async messaging and asset updates. We remain embedded between the product and the market instead of reporting from the sidelines, keeping the message honest and up to date.
- Stage conversion and funnel velocity
- Win rate against named alternatives
- Sales cycle length
- Launch-driven pipeline
If your diabetes & cardiometabolic health company needs product marketing leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a product marketing engagement cost for diabetes and cardiometabolic health companies?
We structure product marketing as a fixed monthly fee across a three-to-six-month sprint, with the range determined by the number of audiences you sell to and the amount of evidence translation and asset production required. A single-audience cash-pay company needs a lighter build than a company selling simultaneously to patients, employers, payers, and clinicians.
How soon will we see results from a product marketing engagement?
Within about 60 days, you will have a tested messaging architecture and sales enablement kit, and sales typically notices an immediate difference in demos and objection handling. Funnel metrics such as conversion and cycle length require a complete sales cycle to shift, which can be lengthy in cardiometabolic care.
How does the product marketing team work with our existing staff?
We embed across your product, sales, and marketing teams instead of operating off to the side. We require access to your product and clinical teams for evidence work, your sales team to develop and test the narrative, and a regulatory contact to clear claims.
How is Winston Francois different from a traditional product marketing agency?
A traditional agency provides a messaging document and deck, then departs. We remain embedded between the product and the market, keep messaging aligned as the product evolves, and make it accountable to funnel metrics.
How is ROI measured for a product marketing engagement?
We track message resonance in demos, stage-to-stage conversion, sales cycle length, and win rate against your named alternatives. For launches, we measure the pipeline the launch directly generated. We benchmark against your pre-engagement baseline so the impact is tangible instead of anecdotal. Since even a single point of win-rate improvement compounds across every deal, the engagement often pays for itself quickly.
What kind of diabetes and cardiometabolic health company is the right fit for this service?
This service is designed for companies between roughly 5M and 100M in ARR that sell to multiple stakeholders and have real clinical evidence not yet translated into buyer-ready messaging. It works particularly well when sales is improvising and launches are not matching their engineering investment. If you are pre-product-market-fit or still defining your core positioning, a lighter positioning engagement is the better place to start. Your first step with us is a strategy call to learn how your buyers describe your product today.
